Developing HTA Landscape in APAC

51:33

US Payers' perspectives on Digital Therapeutics

49:56

Digital Endpoint Strategy and Validation

52:54

Survival analysis in HTA submissions

58:38

Using Historical Controls in Rare Disease Trials

1:00:35

Webinar: Improving Patient Adherence and Outcome Measurement with Game Design

1:09:00

Best practices in seasonal vaccine studies

1:00:09

Overcoming 5 Common Barriers to Harmonised Real World Data

53:23

Effective Ingestion and Normalisation of Real World Data Sources

50:02

Applying the Latest Digital Technology Trends to Patient, Provider and Payer Communications

This webinar reviews current trends and how digital technology and innovation are being applied to patient, healthcare professional, payer, and other decision maker communications.

51:01

Industry Perceptions and Expectations_ The Role of ICER as an Independent HTA

This webinar explores: the evolution of health technology assessment in the US and possibilities for the future; opinions of manufacturers and US payer stakeholders on the role of ICER in the US healthcare system; ICER methodologies and approaches

1:02:20

Industry Analysis_ Impact of FDA’s Recent Guidance on Payer Communications

Our experts explore how manufacturers can successfully implement the FDA's guidance on Payer Communications and integrate these new communication channels with payers

57:23